Travatan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Conditions:   Glaucoma, Open-Angle;   Ocular Hypertension Interventions:   Combination Product: G2TR intraocular implant containing travoprost;   Drug: Sham surgery + active-comparator eye drops Sponsor:   Glaukos Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2018 Category: Research Source Type: clinical trials